Hematopoietic stem cell transplantation procedures

References

• Jacobson L, Marks E, Robson M, et al. Effect of spleen protection on mortality following X-irradiation. J Lab Clin Med 1949; 34: 1538–1543
   Web of Science ®Google Scholar
• Thomas ED, Lochte HL, Jr., Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957; 257(11)491–496
   PubMed Web of Science ®Google Scholar
• Kurnick NB, Montano A, Gerdes JC, Feder BH. Preliminary observations on the treatment of postirradiation hematopoietic depression in man by the infusion of stored autogenous bone marrow. Ann Intern Med 1958; 49(5)973–986
   PubMedGoogle Scholar
• Thomas ED, Buckner CD, Banaji M, et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 1977; 49(4)511–533
   PubMed Web of Science ®Google Scholar
• Carella AM, Bregni M. Current role of allogeneic stem cell transplantation in breast cancer. Ann Oncol 2007; 18(10)1591–1593
   PubMedGoogle Scholar
• Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe. Bone Marrow Transplant 2006; 37(5)439–449
   PubMedGoogle Scholar
• van Bekkum DW. Stem cell transplantation in experimental models of autoimmune disease. J Clin Immunol 2000; 20(1)10–16
   PubMed Web of Science ®Google Scholar
• Marmont A, Tyndall A, Gratwohl A, Vischer T. Hematopoietic precursor-cell transplants for autoimmune-diseases. Lancet 1995; 345: 978
   PubMed Web of Science ®Google Scholar
• Gluckman E. Cord blood transplantation. Biol Blood Marrow Transplant 2006; 12(8)808–812
   PubMedGoogle Scholar
• Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324(10)667–674
   PubMed Web of Science ®Google Scholar
• Zikos P, Van Lint MT, Lamparelli T, et al. Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: Favorable impact of chronic graft-versus-host disease on survival and relapse. Haematologica 1998; 83(10)896–903
   PubMed Web of Science ®Google Scholar
• Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature 2001; 411(6835)385–389
   PubMed Web of Science ®Google Scholar
• Van Wijmeersch B, Sprangers B, Rutgeerts O. Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: Evidence for a graft-versus-autoimmunity effect. Biol Blood Marrow Transplant 2007; 13(6)627–637
   PubMed Web of Science ®Google Scholar
• Hinterberger W, Hinterberger-Fischer M, Marmont A. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002; 30(11)753–759
   PubMed Web of Science ®Google Scholar
• Marmont AM, Gualandi F, Van Lint MT, Bacigalupo A. Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 2003; 31(5)399–402
   PubMed Web of Science ®Google Scholar
• Hayden PJ, Crampe M, Lawler M, et al. Use of DLI to achieve complete donor chimerism in a patient receiving systemic immunosuppression for refractory AIHA post-NST. Bone Marrow Transplant 2005; 36(8)735–736
   PubMedGoogle Scholar
• van Oosterhout M, Verburg RJ, Levarht EW, et al. High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: Poor response associated with persistence of host autoantibodies and synovial abnormalities. Ann Rheum Dis 2005; 64(12)1783–1785
   PubMed Web of Science ®Google Scholar
• Mukaide H, Adachi Y, Koike-Kiriyama N, et al. Immunotherapy for malignant tumors using combination of allogeneic intra-bone marrow–bone marrow transplantation, donor lymphocyte infusion and dendritic cells. Int J Oncol 2007; 30(6)1309–1315
   PubMedGoogle Scholar
• Koike Y, Adachi Y, Suzuki Y, et al. Allogeneic intrabone marrow–bone marrow transplantation plus donor lymphocyte infusion suppresses growth of colon cancer cells implanted in skin and liver of rats. Stem Cells 2007; 25(2)385–391
   PubMedGoogle Scholar
• Carrier E, Burt R. Mobilization and conditioning regimens in stem cell transplant for autoimmune diseases. Stem cell therapy for autoimmune disease, RK Burt, AM Marmont, 2004, Chapter 31
   Google Scholar
• Burt RK, Fassas A, Snowden J, et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001; 28(1)1–12
   PubMed Web of Science ®Google Scholar
• Gazitt Y, Freytes CO, Akay C, et al. Improved mobilization of peripheral blood CD34+ cells and dendritic cells by AMD3100 plus granulocyte-colony-stimulating factor in non-Hodgkin's lymphoma patients. Stem Cells Dev 2007; 16(4)657–666
   PubMedGoogle Scholar
• Oelschlaegel U, Bornhauser M, Boxberger S, et al. Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myeloma. Ann Hematol 2007; 86(8)569–573
   PubMedGoogle Scholar
• Russell NH, Hunter A, Rogers S, et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993; 341(8858)1482
   PubMedGoogle Scholar
• Statkute L, Verda L, Oyama Y, et al. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39(6)317–329
   PubMedGoogle Scholar
• Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344(3)175–181
   PubMed Web of Science ®Google Scholar
• Moore J, Brooks P, Milliken S, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002; 46(9)2301–2309
   PubMed Web of Science ®Google Scholar
• Ferrara JL, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-versus-host disease. Biol Blood Marrow Transplant 1999; 5(6)347–356
   PubMedGoogle Scholar
• Fassas A, Anagnostopoulos A, Kazis A, et al. Autologous stem cell transplantation in progressive multiple sclerosis—an interim analysis of efficacy. J Clin Immunol 2000; 20(1)24–30
   PubMedGoogle Scholar
• Gratwohl A, Passweg J, Bocelli-Tyndall C, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005; 35(9)869–879
   PubMed Web of Science ®Google Scholar
• Openshaw H, Stuve O, Antel JP, et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 2000; 54(11)2147–2150
   PubMedGoogle Scholar
• Burt RK, Marmont A, Oyama Y, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006; 54(12)3750–3760
   PubMed Web of Science ®Google Scholar
• Muraro PA, Douek DC, Packer A, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201(5)805–816
   PubMed Web of Science ®Google Scholar
• Bennett CL, Evens AM, Andritsos LA, et al. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: Report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol 2006; 135(5)642–650
   PubMed Web of Science ®Google Scholar
• Falzetti F, Aversa F, Minelli O, Tabilio A. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet 1999; 353(9152)555
   PubMed Web of Science ®Google Scholar
• Yoshida I, Matsuo K, Teshima T, et al. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation. Transfusion 2006; 46(2)186–192
   PubMedGoogle Scholar
• Burt RK, Testor A, Craig R, et al. Hematopoietic stem cell transplantation for autoimmune diseases: What have we learned?. J Autoimmun 2008; 30(3)116–120
   PubMedGoogle Scholar